6-BROMO-8-(TRIFLUOROMETHYL)-2H,3H-[1,2,4]TRIAZOLO[4,3-A]PYRIDIN-3-ONE, 95%, 250mg

6-(4-Fluorophenyl)pyridine-2-carboxylic acid, 97.0%, 250mg

(R)-Morpholine-3-carbonitrile, 97%, 1g

(2E)-1-(2,4-dimethoxyphenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one, 95.0%, 10g

3-(3-methylphenyl)prop-2-ynoic acid, 95.0%, 1g

Ethyl 5-amino-1-(2-fluorobenzyl)-1H-pyrazole-3-carboxylate, 98+%, 25g

ethyl 5-[2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-5-oxovalerate, 97.0%, 1g

N-Phenyl-phthalamic acid, 95.0%, 1g

Peróxido de hidrógeno, 3%, 500 ml, envase de plástico.

1,3,5-Tris(pyrazol-4-yl)benzene, 95%, 250mg

Sodium 4-(3-(4-hydroxyphenyl)-1,1-dioxido-3H-benzo[c][1,2]oxathiol-3-yl)phenolate, 95.0%, 100g

(R)-3-Amino-3-(2,3-dimethoxyphenyl)propanoic acid, 95.0%, 2g

1-[2-(2-pyrimidinyl)-1,3-thiazol-4-yl]methanamine, 95.0%, 1g